Last reviewed · How we verify
NCT04416022
Cervical Gland Area as a Predictor of Success of Labour Induction
trial testing Ultrasound examination in Induced Vaginal Delivery in 100 participants. Status unknown.
7 June 2022
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 7 June 2020 |
| Primary completion | 7 June 2022 |
| Estimated completion | 7 June 2022 |
Drugs / interventions tested
- Ultrasound examination
Conditions studied
- Induced Vaginal Delivery — all drugs for Induced Vaginal Delivery →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
Adults 18 to 45, female only, with Induced Vaginal Delivery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women who fulfil the inclusion criteria and who are planned for labour induction will be recruited. Bishop score, cervical length, and the presence of cervical glandular area (CGA) will be documented for every patient up to 12 hours prior to the induction process, and patient information and maternal and neonatal outcome will be documented following the delivery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04416022
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound examination
Trials testing the same drug.
- NCT06373029 — Deep-learning Enabled Ultrasound Diagnosis of Anterior Talofibular Ligament Injury · not yet recruiting
- NCT05845775 — Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications · completed
- NCT05792098 — Percutaneous Dilatational Tracheostomy and Thyroid Isthmus Penetration · NA · unknown
- NCT05033574 — The State of Sexual Development in Children With Inherited Epidermolysis Bullosa · unknown
- NCT04074070 — Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal Com · completed
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04416022 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 4 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04416022.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing